Replies to post #306483 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Tangui and Vamvakides

J Espallergues, P Lapalud, A Christopoulos, V A Avlani, P M Sexton, A Vamvakides, T Maurice (2007) Involvement of the sigma1 (sigma1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41. Br J Pharmacol 152: 2. 267-279 Sep.

Vanessa Villard, Julie Espallergues, Emeline Keller, Tursun Alkam, Atsumi Nitta, KIyofumi Yamada, Toshitaka Nabeshima, Alexandre Vamvakides, Tangui Maurice (2009) Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid beta(25-35)-Induced Toxicity in Mice. Neuropsychopharmacology 34: 6. 1552-1566 Dec.

Vanessa Villard, Julie Espallergues, Emeline Keller, Alexandre Vamvakides, Tangui Maurice (2010) Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 ({sigma}1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative. J Psychopharmacol Sep.

Valentine Lahmy, Johann Meunier, Susanna Malmström, Gaelle Naert, Laurent Givalois, Seung Hyun Kim, Vanessa Villard, Alexandre Vamvakides, Tangui Maurice (2013) Blockade of Tau hyperphosphorylation and Aß1?42 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and s1 receptor agonist, in a nontransgenic mouse model of Alzheimer's disease. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 38: 9. 1706-1723 Aug.

Good luck and GOD bless,